Akahoshi, Y., Igarashi, A., Fukuda, T., Uchida, N., Tanaka, M., Ozawa, Y., Kanda, Y., Onizuka, M., Ichinoe, T., Tanaka, J., Atsuta, Y. & Kako, S. (2020) Impact of graft-versus-host disease and graft-versusleukemia effect based on minimal residual disease in Philadelphia chromosome-positive acute lymphoblastic leukemia. British Journal of Haematology, 190, https://doi.org/10.1111/bjh.16540
Appelbaum, F.R. (1997) Graft versus leukemia (GvL) in the therapy of acute lymphoblastic leukemia (ALL). Leukemia, 11, S15–S17.
Baron, F., Maris, M.B., Sandmaier, B.M., Storer, B.E., Sorror, M., Diaconescu, R., Woolfrey, A.E., Chauncey, T.R., Flowers, M.E.D., Mielcarek, M., Maloney, D.G. & Storb, R. (2005) Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Journal of Clinical Oncology, 23, 1993–2003.
Bleakley, M. & Riddell, S.R. (2004) Molecules and mechanisms of the graft-versus-leukaemia effect. Nature Reviews Cancer, 4, 371–380.
Dickinson, A.M., Norden, J., Li, S., Hromadnikova, I., Schmid, C., Schmetzer, H. & Jochem-Kolb, H. (2017) Graft-versus-leukemia effect following hematopoietic stem cell transplantation for leukemia. Frontiers in Immunology, 8, 496.
Giebel, S., Labopin, M., Czerw, T., Socie, G., Blaise, D., Ghavamzadeh, A., Passweg, J., Ljungman, P., Poire, X., Chevallier, P., Remenyi, P., Rambaldi, A., Anafasyev, B., Fegueux, N., Rovira, M., Itala-Remes, M., Bornhauser, M., Mohty, M. & Nagler, A. (2019) Impact of anti-thymocyte globulin on results of allogeneic peripheral blood stem cell transplantation for patients with Philadelphia-positive acute lymphoblastic leukaemia: an analysis by the Acute Leukemia Working Party of the EBMT. European Journal of Cancer, 106, 212–219.
Pavlu, J., Labopin, M., Niittyvuopio, R., Socie, G., Yakoub-Agha, I., Wu, D., Remenyi, P., Passweg, J., Beelen, D.W., Aljurf, M., Kroger, N., Labussiere-Wallet, H., Peric, Z., Giebel, S., Nagler, A. & Mohty, M. (2019) Measurable residual disease at myeloablative allogeneic transplantation in adults with acute lymphoblastic leukemia: a retrospective registry study on 2780 patients from the acute leukemia working party of the EBMT. Journal of Hematology & Oncology, 12, 108.
Stern, M., de Wreede, L.C., Brand, R., van Biezen, A., Dreger, P., Mohty, M., de Witte, T.M., Kroger, N. & Ruutu, T. (2014) Sensitivity of hematological malignancies to graft-versus-host effects: an EBMT megafile analysis. Leukemia, 28, 2235–2240.
Storer, B.E. (2009) Statistical considerations in studies of late effects in HCT. Biology of Blood and Marrow Transplantation, 15, 25–28.
Weiden, P.L., Sullivan, K.M., Flournoy, N., Storb, R., Thomas, E.D.;Seattle Marrow Transplant Team. (1981) Antileukemic effect of chronic graft-versus-host disease. Contribution to improved survival after allogeneic marrow transplantation. New England Journal of Medicine, 304, 1529–1533.
Yeshurun, M., Weisdorf, D., Rowe, J.M., Tallman, M.S., Zhang, M.J., Wang, H.L., Saber, W., de Lima, M., Sandmaier, B.M., Uy, G., Kamble, R.T., Cairo, M.S., Cooper, B.W., Cahn, J.Y., Ganguly, S., Camitta, B., Verdonck, L.F., Dandoy, C., Diaz, M.A., Savani, B.N., George, B., Liesveld, J., McGuirk, J., Byrne, M., Grunwald, M.R., Drobyski, W.R., Pulsipher, M.A., Abdel-Azim, H., Prestidge, T., Wieduwilt, M.J., Martino, R., Norkin, M., Beitinjaneh, A., Seo, S., Nishihori, T., Wirk, B., Frangoul, H., Bashey, A., Mori, S., Marks, D.I. & Bachanova, V. (2019) The impact of the graft-versus-leukemia effect on survival in acute lymphoblastic leukemia. Blood Advances, 3, 670–680.
